INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA SYNERGISTICALLY STIMULATE PROSTAGLANDIN E-2-DEPENDENT PRODUCTION OF INTERLEUKIN-11 IN RHEUMATOID SYNOVIAL FIBROBLASTS
T. Mino et al., INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA SYNERGISTICALLY STIMULATE PROSTAGLANDIN E-2-DEPENDENT PRODUCTION OF INTERLEUKIN-11 IN RHEUMATOID SYNOVIAL FIBROBLASTS, Arthritis and rheumatism, 41(11), 1998, pp. 2004-2013
Objective. In terleukin-11 (IL-11), an IL-6-type cytokine, is thought
to be involved in bone resorption cia osteoclast differentiation. Here
, we characterized the combined effect of IL-1 alpha and tumor necrosi
s factor alpha (TNF alpha), major cytokines in the rheumatoid synovium
, on the production of IL-11 by cultured rheumatoid synovial fibroblas
ts (RSFs), Methods. The amounts of IL-11, IL-6, and prostaglandin E-2
(PGE(2)) were measured by enzyme-linked immunosorbent assay. IL-11 mes
senger RNA (mRNA) levels were determined by Northern blotting. Protein
expression of cytosolic phospholipase A(2) (cPLA(2)), cyclooxygenase
2 (COX-2), and protein kinase C (PKC) isoforms were determined by West
ern blotting. Results. 1L-1 alpha and TNF alpha synergistically stimul
ated RSFs to produce IL-11 at both the mRNA and protein levels. This s
ynergistic effect was completely inhibited by indomethacin, The inhibi
tion was prevented by PGE(2), indicating that the synergistic effect o
f IL-1 alpha and TNF alpha was PGE(2)-mediated, The cooperative effect
s of these 2 cytokines were also observed in the production of PGE(2)
and the expression of 2 regulatory enzymes in PGE(2) production, cPLA(
2) and COX-2, The synergistic induction of IL-11 by IL-1 alpha and TNF
alpha was completely inhibited by a potent inhibitor of all isoforms
of PKC, GF109203X. In contrast, phorbol myristate acetate, which induc
ed a down-regulation of PKC, degrading all PKC isoforms except atypica
l PKC, did not affect the induction of IL-11, Conclusion. These findin
gs suggest that IL-1 alpha and TNF alpha synergistically stimulate the
production of IL-11 via their effects on PGE(2) production in the rhe
umatoid joint, and that atypical PKC may be another target for down-re
gulation of IL-11, the bone resorption-associated cytokine.